Abstracts Archive - Page 1979 of 2425 - ACR Meeting Abstracts

Abstract Number: 1083 • 2014 ACR/ARHP Annual Meeting
The Relation of Step Length to MRI Features of Osteoarthritis in the Patellofemoral Joint: The MOST Study
Joshua Stefanik¹, K. Douglas Gross², David T. Felson³, Jingbo Niu⁴, Daniel K. White⁵, Ali Guermazi⁶, Frank Roemer⁷, C.E. Lewis⁸, Neil A. Segal⁹, Michael Nevitt¹⁰ and Cara Lewis¹¹, ¹Clinical Epidemiology, Boston University, Boston, MA, ²Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, ³Clinical Epidemiology Research & Training Unit, Boston University School of Medicine, Boston, MA, ⁴Clinical Epidemiology Research and Training Unit, Boston University, Boston, MA, ⁵Department of Physical Therapy, University of Delaware, Newark, DE, ⁶Radiology, Boston University School of Medicine, Boston, MA, ⁷Klinikum Augsburg, Augsburg, Germany, ⁸University of Alabama at Birmingham, Birmingham City, AL, ⁹Orthopaedics and Rehabilitation, University of Iowa, Iowa City, IA, ¹⁰Epidemiology and Biostatistics, UCSF, San Francisco, CA, ¹¹Physical Therapy and Athletic Training, Boston University, Boston, MA
Background/Purpose: Patellofemoral joint (PFJ) osteoarthritis (OA) is a common source of pain and there is little evidence for rehabilitation treatment. Gait retraining treatments are effective…
Abstract Number: 1082 • 2014 ACR/ARHP Annual Meeting
Risk of Intra Cranial Hemorrhage among Patients with Anti-Phospho-Lipid-Antibody (aPL) syndrome vs Systemic Lupus Erythematosus (SLE) in Stroke Population: A Nationwide Analysis
Tapan Mehta¹, Khushboo Sheth², Ronak Soni³, Sonam Puri² and Kathan Mehta⁴, ¹Neurology, University of Connecticut, Farmington, CT, Farmington, CT, ²Internal Medicine, University of Connecticut, Farmington, CT, Farmington, CT, ³Internal Medicine, Government Medical College, Surat, India, ⁴Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, Pittsburgh, PA
Background/Purpose Central nervous system involvement is common in Systemic Lupus Erythematosus (SLE) and was first described in 1873. Though ischemic involvement is more common than…
Abstract Number: 1081 • 2014 ACR/ARHP Annual Meeting
Prediction of Mortality Risk Related to Cerebrovascular Accidents in Patients with Systemic Lupus Erythematosus (SLE) vs Anti-Phospho-Lipid-Antibody (aPL) syndrome
Khushboo Sheth¹, Tapan Mehta², Sonam Puri¹, Ronak Soni³ and Kathan Mehta⁴, ¹Internal Medicine, University of Connecticut, Farmington, CT, Farmington, CT, ²Neurology, University of Connecticut, Farmington, CT, Farmington, CT, ³Internal Medicine, Government Medical College, Surat, India, ⁴Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, Pittsburgh, PA
Background/Purpose : It is well-established that patients with co-existent Systemic Lupus Erythematosus (SLE) and Anti-Phospho-Lipid-Antibody (aPL) syndrome are at increased risk of cerebrovascular accidents (CVA).…
Abstract Number: 1100 • 2014 ACR/ARHP Annual Meeting
System Review: The Most Common Symptoms of Fibromyalgia Patients Other Than Pain, Fatigue, Insomnia, and Cognitive Dysfunction
Robert S. Katz¹ and Jessica L. Polyak², ¹Rush Medical College, Chicago, IL, ²Rheumatology Associates, Chicago, IL
Background/Purpose: Fibromyalgia patients are somatically sensitive. The frequently complain of symptoms other than the core ones used for the diagnosis- pain, fatigue, poor sleep and…
Abstract Number: 1099 • 2014 ACR/ARHP Annual Meeting
Which Stresses Bother Fibromyalgia Patients Most?
Robert S. Katz¹, Alexandra Small² and Jessica L. Polyak³, ¹Rush Medical College, Chicago, IL, ²University of Illinois College of Medicine, Chicago, IL, ³Rheumatology Associates, Chicago, IL
Background/Purpose: Fibromyalgia patients identify stress as a factor in aggravating their pain and other symptoms. We administered a questionnaire to fibromyalgia patients to try to…
Abstract Number: 1098 • 2014 ACR/ARHP Annual Meeting
Clinical Efficacy of the High-Concentration Capsaicin Patch for the Treatment of Carpal Tunnel Syndrome
Olga Sleglova¹ and Marek Hakl², ¹Institute of Rheumatology, Prague, Prague, Czech Republic, ²Pain Department Faculty Hospital Saint Anna, Brno, Brno, Czech Republic
Background/Purpose: Carpal tunnel syndrome (CTS) is a clinical syndrome manifested by signs and symptoms of irritation of the median nerve at the level of the carpal tunnel in the…
Abstract Number: 1097 • 2014 ACR/ARHP Annual Meeting
Can We Help Identify Learning Disabilities in Fibromyalgia Patients?
Robert S. Katz¹, Lauren Kwan² and Jessica L. Polyak², ¹Rush Medical College, Chicago, IL, ²Rheumatology Associates, Chicago, IL
Background/Purpose: A previous study (ArthRheum;S10:956) has shown that Fibromyalgia syndrome (FMS) patients may have learning disabilities. Experts in the field have identified seven types of…
Abstract Number: 1096 • 2014 ACR/ARHP Annual Meeting
Fibromyalgia Patients Who Have More Symptoms at Their Initial Office Visit Tend to Have a Worse Clinical Course
Robert S. Katz¹, Ben J. Small², Alexandra Small³ and Hannah Bond⁴, ¹Rush Medical College, Chicago, IL, ²MacNeal Hospital, Berwyn, IL, ³University of Illinois College of Medicine, Chicago, IL, ⁴Rheumatology Associates, Chicago, IL
Background/Purpose: Patients with the fibromyalgia syndrome (FMS) experience pain, insomnia, fatigue, and memory/concentration problems. But some fibromyalgia patients also have many additional somatic symptoms. We…
Abstract Number: 1095 • 2014 ACR/ARHP Annual Meeting
Treatment of Fibromyalgia with Neurostimulation: A Randomized, Double-Blinded, Sham-Controlled Trial
R Michael Gendreau^1,2, Donald Deering³, Judith Gendreau¹ and Jeffrey Hargrove⁴, ¹Gendreau Consulting, LLC, Poway, CA, ²Cerephex Corporation, Los Altos, CA, ³St. Joseph Mercy Oakland, Pontiac, MI, ⁴Research & Development, Cerephex Corporation, Los Altos, CA
Background/Purpose: NeuroPoint is a medical device designed to provide noninvasive brain stimulation using a proprietary approach to deliver very low energy levels to deep brain…
Abstract Number: 1094 • 2014 ACR/ARHP Annual Meeting
Work Productivity and Healthcare Utilization in Patients with Fibromyalgia and Comorbid Depression Taking Antidepressant Medication
Jaren Landen¹, Claire Burbridge², Elizabeth Masters³, Pritha Bhadra Brown⁴, Joseph Scavone¹, Birol Emir⁴, Richard Vissing⁵, Andrew Clair⁴ and Lynne Pauer⁶, ¹Pfizer Inc, Groton, CT, ²Pfizer Ltd, Walton Oaks, United Kingdom, ³Health Economics and Outcomes Research, Pfizer Inc, New York, NY, ⁴Pfizer Inc, New York, NY, ⁵Pfizer Inc, Louisville, KY, ⁶445 Eastern Point Road, Pfizer Inc, Groton, CT
Background/Purpose Patients with fibromyalgia (FM) experience pain, sleep disruption, fatigue, and other symptoms that limit activity, impacting work productivity and increasing healthcare utilization. Here, we…
Abstract Number: 1093 • 2014 ACR/ARHP Annual Meeting
Female Sexual Function in Fibromyalgia
Maria Julieta Gamba¹, Claudia Uña¹, Alicia Igel¹, Fernando Eraña¹, Maritza Vidal¹, Gimena Gómez², Griselda Redondo¹, Maria Celina de la Vega¹, Estella Chiuzzi¹, Augusto Martin Riopedre Sr.¹, Maria Ines de la Barrera³, Norma Villa¹, Dario Mata¹, Alba Russo¹ and Osvaldo Daniel Messina¹, ¹REUMATOLOGIA, HOSPITAL ARGERICH, BUENOS AIRES, Argentina, ²Hospital Argerich, Buenos Aires, Argentina, ³HOSPITAL ARGERICH, HOSPITAL ARGERICH, BUENOS AIRES, Argentina
Background/Purpose: Fibromyalgia (FM) is a common condition in young and middle-aged women, which is mainly characterized by diffuse chronic pain and is associated with other…
Abstract Number: 1092 • 2014 ACR/ARHP Annual Meeting
Does Arthritis Status Predict Starting or Stopping Work over a 2-Year Period?
Kristina A. Theis¹, Miriam Cisternas² and Louise Murphy³, ¹Athritis Program, Centers for Disease Control and Prevention, Atlanta, GA, ²MGC Data Services, San Diego, CA, ³Division of Population Health, Centers for Disease Control and Prevention, Atlanta, GA
Background/Purpose Employment is linked to prosperity, identity, and the ability to contribute to society. Lower employment is well documented among adults with arthritis, but less…
Abstract Number: 1091 • 2014 ACR/ARHP Annual Meeting
Skeletal Muscle Fat and Its Association with Physical Function and Physical Activity in Adults with Rheumatoid Arthritis
Samannaaz S. Khoja¹, Bret Goodpaster² and Sara R. Piva³, ¹Department of Physical Therapy, University of Pittsburgh, Pittsburgh, PA, ²Sandford Burnham Medical Research Institute, Lake Nona in Orlando, FL, ³Physical Therapy, University of Pittsburgh, Pittsburgh, PA
Background/Purpose: Systemic inflammation in RA not only affects joints, but also body composition. People with RA tend to have lower lean body mass and higher…
Abstract Number: 1073 • 2014 ACR/ARHP Annual Meeting
Prescription Medication Trends in Medicaid-Enrolled Pregnant Women with Rheumatoid Arthritis, Psoriasis, and Systemic Lupus Erythematosus
Rishi Desai¹, Krista Huybrechts², Brian Bateman², Helen Mogun², Sonia Hernandez-diaz³ and Seoyoung C. Kim⁴, ¹PharmacoEpidemiology & PharmacoEconomics, Brigham and Women's Hospital, Boston, MA, ²Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital, Boston, MA, ³Harvard School of Public Health, Boston, MA, ⁴Div. of Pharmacoepidemiology and Pharmacoeconomics, Div. of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA
Background/Purpose: Little is known about the trends of medication use in pregnant women with autoimmune disorders. The objective of the current study was to…
Abstract Number: 1071 • 2014 ACR/ARHP Annual Meeting
What Is the Impact of Chronic Systemic Inflammation Such As Rheumatoid Arthritis on Mortality Following Cancer?
Julia Simard^1,2, Sara Ekberg³, Anna Johansson⁴ and Johan Askling^2,5, ¹Division of Epidemiology, Health Research and Policy Department, and Division of Immunology & Rheumatology, Department of Medicine, Stanford School of Medicine, Stanford, CA, ²Clinical Epidemiology Unit, Dept of Medicine, Karolinska Institutet, Stockholm, Sweden, ³Dept of Medical Epidemiology of Biostatistic, Karolinska Institutet, Stockholm, Sweden, ⁴Dept of Medical Epidemiology and Biostatistics, Karolinska Institutet, stockholm, Sweden, ⁵Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden
Background/Purpose: Emerging evidence links inflammation and immune-competence to cancer progression and outcome. The few studies addressing cancer survival in the context of systemic inflammation,…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].